Transitional arrangements

The Podiatry Board of Australia’s revised registration standard for endorsement for scheduled medicines and associated guidelines came into effect on 1 August 2018. Information about the new standard and guidelines can be found on the Endorsement for scheduled medicines page.

Recognising that there were practitioners working towards an endorsement under Pathway 2 of the previous registration standard when the new registration standard took effect, the Board has developed transitional arrangements. The transitional arrangements allow these practitioners to continue under Pathway 2 or switch to Pathway B of the new registration standard.

The transitional arrangements are outlined in the Transitional arrangements for the new Registration standard: Endorsement for scheduled medicines, available below.

An easy to follow summary is in the Flowchart: A summary of transitional arrangements for the new Endorsement for scheduled medicines registration standard, available below.

Document name PDF Accessible format Document date
Transitional arrangements for the new Registration standard: Endorsement for scheduled medicines PDF 
(219KB)
Word version 
(88.4KB,DOCX)
30 April 2018
Flowchart: A summary of transitional arrangements for the new Endorsement for scheduled medicines registration standard PDF 
(51.0KB)
Word version 
(358KB,DOCX)
30 April 2018

There are important timelines you must meet if you want to use the transitional arrangements.

  • by 1 September 2018,you must advise the Board whether you are continuing under Pathway 2 of the previous registration standard or changing to Pathway B of the new registration standard and submit the following documents:
    • evidence of your approved qualification in podiatric therapeutics (not more than seven years old) 
    • evidence of successful completion of web-based case studies (completed not more than three years ago), and 
    • a signed supervisory agreement (dated and signed before 1 August 2018).

      A form for submitting these documents is published on the on the Forms page.

  • By 1 September 2019 you must submit your application for endorsement.

The documents below are only relevant if you are using the transitional arrangements to continue under Pathway 2 of the previous endorsement for scheduled medicines registration standard.

If you are using the transitional arrangements to continue under Pathway B of the new endorsement for scheduled medicines registration standard, information about the new registration standard and guidelines can be found on the Endorsement for scheduled medicines page.

Retired versions

Document name  PDF  Accessible format Document date 
Endorsement for scheduled medicines registration standard  PDF 
(250 KB) 
  01 July 2010 
Podiatry guidelines for endorsement for scheduled medicines  PDF 
(811 KB) 
  01 July 2010 
Endorsement for scheduled medicines: Information package  PDF 
(779 KB) 
  30 September 2011 
Podiatry policy on log sheets for endorsement for scheduled medicines  PDF 
(74.9 KB) 
  28 December 2011 
Template log sheet for endorsement for scheduled medicines    Word version 
(290 KB,DOC) 
7 July 2016 
Sample log sheet for endorsement for scheduled medicines  PDF 
(129 KB) 
19 March 2012 

Board approved web-based case studies

One of the requirements for podiatrists or podiatric surgeons who are following Pathway 2 towards applying to the Board to have their registration endorsed for scheduled medicines is the successful completion of 15 web-based case studies approved by the Board.

The Board has approved the following web-based case studies for the purpose of endorsement for scheduled medicines:

  • Web-based case studies offered by LaTrobe University
  • Web-based case studies offered by the Queensland University of Technology (QUT) as part of the Graduate Certificate in Podiatric Therapeutics

Supplementary information

Copies of documents provided in support of an application, or other purpose required by the National Law, must be certified as true copies of the original documents.

See Certifying Documents on the AHPRA web site. 

 
 
Page reviewed 1/08/2018